National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan's envoy meets U.S. treasury secretary, Japan PM at APEC
10/31/2025 10:26 PM - Business
Taiwan's Q3 economic growth may reach 7.64%: DGBAS
10/31/2025 09:59 PM - Politics
Nov. 28 set as voting day for Taiwan's 2026 local elections
10/31/2025 09:34 PM - Politics
Incoming KMT chair doubles down on 'Putin was elected' remarks
10/31/2025 08:26 PM - Society
Rain, cooler temperatures forecast for northern Taiwan
10/31/2025 07:44 PM